Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Revamil
- Development stage
- Unknown
- Lead developer
- Vrije University Medical Center
- Modality
- Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Administration
- Topical
01
Overview
Revamil is a medical-grade, standardized medicinal honey (RS honey) developed for wound care and the prevention of infections. Produced under controlled greenhouse conditions by Bfactory Health Products, it is sterilized and classified as a type IIb medical device. Its antimicrobial activity is multifaceted, resulting from a high sugar concentration (osmotic effect), the production of hydrogen peroxide (H₂O₂), the presence of methylglyoxal (MGO) and the cationic antimicrobial peptide bee defensin-1, and a low pH. Revamil exhibits broad-spectrum antibacterial activity against drug-sensitive and drug-resistant pathogens, including MRSA, ESBL-producing E. coli, and VRE. It is primarily used for chronic and infected wounds and has been investigated for reducing skin colonization in intensive care patients to prevent catheter-related bloodstream infections.
- Brand names
- Revamil
- Other names
- medicinal honeymedical-grade honey
Beyond the preview
Go deeper on Revamil.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Revamil.